Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.
Grolleau C, Mahévas T, Daniel P, Schleinitz N, Seneschal J, Doutre MS, Richez C, Rigolet A, Champtiaux N, Combemale L, Langlois V, Jacobzone-Leveque C, Vautier M, Toussaint C, Delpuech A, Paul C, Dupin N, Bugaut H, Chasset F, Lesort C, Paule R, Gallay L, Charvet E, Jachiet M, Cassius C, Bouaziz JD, Benveniste O, Allenbach Y, EMSED study group
Journal of the European Academy of Dermatology and VenereologyIn the feed 14 Jul 2026, published online 14 Jul 2026, issue 2026 Jul 14, added to PubMed 14 Jul 2026
Topics: Autoimmune & connective tissueBiologics
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42447155 · DOI 10.1111/jdv.70580